Tioga Medical, a Campbell CA-based Shifamed portfolio company that develops a valve replacement solution for mitral and tricuspid applications, raised $30M in Series B funding.
The round was led by The Capital Partnership (TCP), with participation from Cormorant Asset Management, AMED Ventures and Shifamed angel investors.
The company intends to use the funds to advance product development, support pre-clinical testing, and initiate clinical experience for its transcatheter valve replacement technology.
Led by Mike Dineen, President and CEO, Tioga is focused on providing valve replacement solutions for mitral and tricuspid applications that are procedurally symple and use a less invasive, transcatheter approach.
FinSMEs
07/07/2021